Want to see KR:067630 full AI Analyst Report?
HLB Life Science Co.,Ltd. (067630) Financial Statements
HLB Life Science Co.,Ltd. Financial Overview
HLB Life Science Co.,Ltd.'s market cap is currently $401.49B. The company's EPS TTM is $-876.55; its P/E ratio is -32.21; HLB Life Science Co.,Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 45.75B | $ 102.24B | $ 97.99B | $ 99.59B | $ 53.49B |
| Gross Profit | $ -494.41M | $ -2.19B | $ -748.57M | $ -3.05B | $ -5.54B |
| Operating Income | $ -21.02B | $ -24.82B | $ -24.53B | $ -20.16B | $ -18.48B |
| EBITDA | $ -83.58B | $ 25.87B | $ 22.84B | $ -45.75B | $ -49.88B |
| Net Income | $ -99.79B | $ 6.14B | $ -5.98B | $ -54.36B | $ -49.29B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.88B | $ 79.57B | $ 78.86B | $ 131.44B | $ 139.96B |
| Total Assets | $ 478.09B | $ 539.02B | $ 423.50B | $ 411.79B | $ 270.80B |
| Total Debt | $ 160.36B | $ 123.78B | $ 166.58B | $ 147.47B | $ 4.62B |
| Net Debt | $ 147.07B | $ 71.06B | $ 149.81B | $ 116.49B | $ -26.63B |
| Total Liabilities | $ 180.35B | $ 140.19B | $ 192.29B | $ 175.72B | $ 24.19B |
| Stockholders' Equity | $ 297.35B | $ 398.34B | $ 230.80B | $ 234.72B | $ 246.19B |
| Cash Flow | |||||
| Free Cash Flow | $ -48.88B | $ -59.47B | $ -31.54B | $ -41.40B | $ -16.69B |
| Operating Cash Flow | $ -22.93B | $ -32.01B | $ -10.02B | $ -29.74B | $ -14.08B |
| Investing Cash Flow | $ -34.63B | $ -37.78B | $ -8.88B | $ -72.64B | $ 8.82B |
| Financing Cash Flow | $ 18.26B | $ 105.74B | $ 4.79B | $ 102.10B | $ -641.09M |
Currency in KRW
